Metraipolis › archive › dc_429fe98a526c

Retinal gene therapy using epiretinal AAV-containing fibrin hydrogel implants — Europe PMC PMID:40911667

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40911667
DOI
10.1126/sciadv.adv7922
License (as archived)
solo-consultazione
Archived
2026-11-10T03:09:24.448Z
SHA-256 of the archived text
5d79e4451afbbbd23cb58a1668bee8781a3ba137a91cf0afb53cfb2757cf3463
Stable URL of this page
https://metraipolis.com/documento/dc_429fe98a526c

How to cite

Retinal gene therapy using epiretinal AAV-containing fibrin hydrogel implants — Europe PMC PMID:40911667 — Europe PMC (en), https://europepmc.org/article/MED/40911667 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_429fe98a526c (Metraipolis archive dc_429fe98a526c, sha256 5d79e4451afbbbd23cb58a1668bee8781a3ba137a91cf0afb53cfb2757cf3463)
BibTeX
@misc{dc429fe98a526c,
  title = {Retinal gene therapy using epiretinal AAV-containing fibrin hydrogel implants — Europe PMC PMID:40911667},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40911667},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_429fe98a526c; sha256 5d79e4451afbbbd23cb58a1668bee8781a3ba137a91cf0afb53cfb2757cf3463},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40911667. Agents can read the archived copy with the MCP tool read_document.